From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Lipid Management>
  4. Archives

Lipid Management: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 76-100 of 354 are shown

AIM-HIGH Halted: A Death Knell for the HDL Hypothesis? Six Experts Weigh In

Raising HDL levels with niacin failed to affect clinical outcomes.

No Benefit of Aspirin or Statins in Pulmonary Arterial Hypertension

Neither reduced thromboxane B2 levels nor improved lipid profiles had any effect on 6-minute walk distances.

Five Lessons from Niaspan's Disappointing Study

Adapted from a post on Dr. Harlan Krumholz's Outcomes blog at Forbes.com

High-Selenium Yeast Supplements Improve Plasma Lipid Levels

But the effects of this treatment in individuals with normal or high baseline selenium concentrations remain unproven, as do clinical outcomes.

Skin Surgery Complications in Patients on Clopidogrel

The drug was associated with significantly increased risk for severe postoperative wound complications.

What Hath COURAGE Wrought? No Change in Practice

Many patients with stable coronary artery disease are still not receiving optimal medical therapy before undergoing percutaneous coronary intervention.

Can We Delay Conversion from Mild Cognitive Impairment to Alzheimer Disease?

Control of vascular risk factors may lower the conversion rate.

HIV Independently Associated with Heart Failure Risk

Observational data suggest that heightened vigilance and aggressive risk-factor management are warranted to prevent HF in HIV-infected individuals.

Statin Use and Risk for Death After Pneumonia

Statin users were significantly less likely to die in the 6 months after pneumonia diagnoses.

Should Statin Therapy Be Continued During Sepsis?

In a randomized, placebo-controlled trial, continuing statin therapy during hospitalization for sepsis neither improved nor worsened outcome.

HDL and Colorectal Cancer Risk

HDL levels were inversely associated with colon cancer risk but showed no association with rectal cancer risk.

Long-Term Statin Therapy Does Not Lower Risk for Atrial Fibrillation

Several factors might explain discrepant results between short-term and long-term trials.

Prescribing of Fibrates Is Booming in the U.S.

But scant evidence from clinical trials supports this trend.

Alcohol Favorably Affects Biomarkers Associated with CHD Risk

Risks for coronary heart disease were similar for drinkers of beer, wine, or spirits.

Bad News for Screen Junkies

Even after accounting for physical activity levels, spending a lot of discretionary time in front of a television or computer is an independent predictor of cardiovascular events.

C-Reactive Protein Level Doesn't Predict Statin Response in High-Risk Patients

Reanalysis of the largest randomized statin trial to date suggests a cardiovascular risk reduction irrespective of baseline CRP levels.

Prevention of Cardiovascular Disease in Women

  • Cardiology
  • Clinical Practice Guideline Watch
  • Free

Revised guidelines redefine risk for cardiovascular disease and its management in women.

Cholesterol Monitoring to Detect Nonadherence to Statin Treatment

Monitoring cholesterol levels won't replace discussing the importance of adherence with patients on statins.

Statins Prevent Vascular Events, Independent of Baseline CRP Levels

Contrary to some claims, statins benefited high-risk patients with low C-reactive protein levels.

Statin Use After Intracerebral Hemorrhage

Under most circumstances, the risks of statin treatment after intracerebral hemorrhage outweigh the potential benefits.

Cardiovascular Risk Assessment in Asymptomatic Adults

  • Cardiology
  • Clinical Practice Guideline Watch
  • Free

<$EMPH_O>New guidelines reflect a conservative approach.<$EMPH_C>

Factors Influencing Patient Adherence to Cardiovascular Medication Regimens

Aspects other than the number and dosage of drugs can have substantial effects.

Statins for Patients with Fatty Liver Disease and Mildly Elevated Transaminases

Benefits seem to outweigh hepatotoxicity risk.

Which Statins Are Best for Treating HIV-Related Dyslipidemia?

In an observational study, atorvastatin and rosuvastatin were more effective than pravastatin, with similar toxicity rates.

ACCORD: Blood Pressure and Lipid Results

For older diabetic patients, a systolic BP target in the 130s probably is best.

Items 76-100 of 354 are shown

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.